» Articles » PMID: 33451164

Oxidative Stress and Inflammation Biomarker Expression in Obstructive Sleep Apnea Patients

Abstract

Obstructive Sleep Apnea Syndrome (OSAS) is a respiratory sleep disorder characterised by repeated episodes of partial or complete obstruction of the upper airway during the night. This obstruction usually occurs with a reduction (hypopnea) or complete cessation (apnea) of the airflow in the upper airways with the persistence of thoracic-diaphragmatic respiratory movements. During the hypopnea/apnea events, poor alveolar ventilation reduces the oxygen saturation in the arterial blood (SaO) and a gradual increase in the partial arterial pressure of carbon dioxide (PaCO). The direct consequence of the intermittent hypoxia is an oxidative imbalance, with reactive oxygen species production and the inflammatory cascade's activation with pro and anti-inflammatory cytokines growth. Tumour necrosis factors, inflammatory cytokines (IL2, IL4, IL6), lipid peroxidation, and cell-free DNA have been found to increase in OSAS patients. However, even though different risk-related markers have been described and analysed in the literature, it has not yet been clarified whether specified inflammatory bio-markers better correlates with OSAS diagnosis and its clinical evolution/comorbidities. We perform a scientific literature review to discuss inflammatory and oxidative stress biomarkers currently tested in OSAS patients and their correlation with the disease's severity and treatment.

Citing Articles

Oxidative stress and reactive oxygen species in otorhinolaryngological diseases: insights from pathophysiology to targeted antioxidant therapies.

Meng L, Liu S, Luo J, Tu Y, Li T, Li P Redox Rep. 2025; 30(1):2458942.

PMID: 39894944 PMC: 11792148. DOI: 10.1080/13510002.2025.2458942.


Retinal microvascular phenotypes can track small vessel disease burden and CPAP treatment effectiveness in obstructive sleep apnoea.

Giarratano Y, Hill E, Hamid C, Wiseman S, Gray C, Chappell F J Cereb Blood Flow Metab. 2024; :271678X241291958.

PMID: 39487754 PMC: 11563513. DOI: 10.1177/0271678X241291958.


Microglia and Sleep Disorders.

Picard K, Dolhan K, Watters J, Tremblay M Adv Neurobiol. 2024; 37:357-377.

PMID: 39207702 DOI: 10.1007/978-3-031-55529-9_20.


Differences and Risk Factors of Peripheral Blood Immune Cells in Patients with Obstructive Sleep Apnea.

Jiang Y, Lin C, Xu M, Zhu T, Li X, Wang W Nat Sci Sleep. 2024; 16:737-749.

PMID: 38882924 PMC: 11178088. DOI: 10.2147/NSS.S458098.


Home-Based Aerobic Interval Training Combined with Resistance Training Improved Daytime Dysfunction in Adults with Obesity and Sleep-Disordered Breathing.

Longlalerng K, Watanasiripakdee S, Jeenduang N, Habuddha V, Piya-Amornphan N, Damchuai T Sleep Sci. 2024; 17(2):e117-e124.

PMID: 38846585 PMC: 11152638. DOI: 10.1055/s-0043-1777708.


References
1.
Liu L, Cao Q, Guo Z, Dai Q . Continuous Positive Airway Pressure in Patients With Obstructive Sleep Apnea and Resistant Hypertension: A Meta-Analysis of Randomized Controlled Trials. J Clin Hypertens (Greenwich). 2015; 18(2):153-8. PMC: 8031627. DOI: 10.1111/jch.12639. View

2.
Ifergane G, Ovanyan A, Toledano R, Goldbart A, Abu-Salame I, Tal A . Obstructive Sleep Apnea in Acute Stroke: A Role for Systemic Inflammation. Stroke. 2016; 47(5):1207-12. DOI: 10.1161/STROKEAHA.115.011749. View

3.
Caimi G, Montana M, Canino B, Calandrino V, Lo Presti R, Hopps E . Erythrocyte deformability, plasma lipid peroxidation and plasma protein oxidation in a group of OSAS subjects. Clin Hemorheol Microcirc. 2016; 64(1):7-14. DOI: 10.3233/CH-152034. View

4.
Borges Y, Cipriano L, Aires R, Zovico P, Vasconcelos Campos F, de Araujo M . Oxidative stress and inflammatory profiles in obstructive sleep apnea: are short-term CPAP or aerobic exercise therapies effective?. Sleep Breath. 2019; 24(2):541-549. DOI: 10.1007/s11325-019-01898-0. View

5.
Paz Y Mar H, Hazen S, Tracy R, Strohl K, Auckley D, Bena J . Effect of Continuous Positive Airway Pressure on Cardiovascular Biomarkers: The Sleep Apnea Stress Randomized Controlled Trial. Chest. 2016; 150(1):80-90. PMC: 4980547. DOI: 10.1016/j.chest.2016.03.002. View